Colinz Laboratories Limited

COLINZ6

INE923C01011

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:53 16/05/2024 BST			5-day change	1st Jan Change
44.01 ^INR	+6.30%		+2.18%	+10.02%

01-31	Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2020

August 14, 2020 at 01:15 pm

Colinz Laboratories Limited announced earnings results for the first quarter ended June 30, 2020. For the first quarter, the company announced total revenue was INR 14.478 million compared to INR 20.533 million a year ago. Net income was INR 542,000 compared to INR 522,000 a year ago. Basic earnings per share was INR 0.3 compared to INR 0.09 a year ago.

Latest news about Colinz Laboratories Limited

Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-31	CI
Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/08/23	CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	30/07/22	CI
Colinz Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	28/05/22	CI
Colinz Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	31/01/22	CI
Colinz Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	30/10/21	CI
Colinz Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2021	30/07/21	CI
Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	27/05/21	CI
Colinz Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	30/01/21	CI
Colinz Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	31/10/20	CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	14/08/20	CI
Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	30/06/20	CI
Colinz Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	31/01/20	CI
Colinz Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	31/10/19	CI
Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	31/07/19	CI
Colinz Laboratories Limited Announces Management Changes	20/05/19	CI
Colinz Laboratories Limited Announces Management Changes	10/05/19	CI
Colinz Laboratories Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	31/10/18	CI
Colinz Laboratories Limited Announces Audited Financial Results for the Quarter and Year Ended March 31, 2018	29/05/18	CI
Colinz Laboratories Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	12/12/17	CI
Colinz Laboratories Limited Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2017	07/09/17	CI
Colinz Laboratories Limited Reports Unaudited Earnings Results for Fourth Quarter and Audited Earnings Results for Full Year Ended Mar. 31, 2017	26/05/17	CI
Colinz Laboratories Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016	28/01/17	CI
Colinz Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2016	28/10/16	CI
Colinz Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2016	30/07/16	CI

Chart Colinz Laboratories Limited

Duration

Period

More charts

Company Profile

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynecological sector. The Company is engaged in the manufacturing and marketing various allopathic and ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. It provides physicians with products in the treatment of hypertension, cholesterol, diabetes, piles, pyrexia and malaria. It provides gynecologists with specialized products in the treatments of morning sickness, infertility, intrauterine growth restriction (IUGR) and maintenance of pregnancy. It also offers other products, such as hematinic, antispasmodics, anti-inflammatory/anti-allergic tablets, capsules gel and medicated shampoo. The Company markets its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh and West Bengal through its own marketing staff.

Sector

Pharmaceuticals

Calendar

26/05/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
COLINZ LABORATORIES LIMITED	+10.02%	1.25M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.98%	43.92B
OTSUKA HOLDINGS CO., LTD.	+24.56%	23.09B
SANDOZ GROUP AG	+19.18%	15.35B
CIPLA LIMITED	+14.03%	13.61B
ZYDUS LIFESCIENCES LIMITED	+46.40%	12.02B
ONO PHARMACEUTICAL CO., LTD.	-10.14%	7B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.6B